The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Biologics in Spine Surgery Market Research Report 2022

Global Biologics in Spine Surgery Market Research Report 2022

Publishing Date : Apr, 2022

License Type :
 

Report Code : 1689076

No of Pages : 92

Synopsis
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
Due to the COVID-19 pandemic, the global Biologics in Spine Surgery market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Biologics in Spine Surgery market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Biologics in Spine Surgery landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Bone Graft accounting for % of the Biologics in Spine Surgery global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Biologics in Spine Surgery include Medtronic, J &J (DePuy Synthes), SeaSpine, Xtant Medical, Zimmer Biomet, Stryker, Straumann, Wright Medical Group and Hans Biomed and etc. In terms of revenue, the global 3 largest players have a % market share of Biologics in Spine Surgery in 2021.
This report focuses on Biologics in Spine Surgery volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Biologics in Spine Surgery market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Biologics in Spine Surgery Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Bone Graft
Bone Graft Substitute
Platelet Rich Plasma (PRP)
Other
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Medtronic
J &J (DePuy Synthes)
SeaSpine
Xtant Medical
Zimmer Biomet
Stryker
Straumann
Wright Medical Group
Hans Biomed
Arthrex
Index
1 Biologics in Spine Surgery Market Overview
1.1 Product Overview and Scope of Biologics in Spine Surgery
1.2 Biologics in Spine Surgery Segment by Type
1.2.1 Global Biologics in Spine Surgery Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Bone Graft
1.2.3 Bone Graft Substitute
1.2.4 Platelet Rich Plasma (PRP)
1.2.5 Other
1.3 Biologics in Spine Surgery Segment by Application
1.3.1 Global Biologics in Spine Surgery Sales Comparison by Application: (2022-2028)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Biologics in Spine Surgery Market Size Estimates and Forecasts
1.4.1 Global Biologics in Spine Surgery Revenue 2017-2028
1.4.2 Global Biologics in Spine Surgery Sales 2017-2028
1.4.3 Biologics in Spine Surgery Market Size by Region: 2017 Versus 2021 Versus 2028
2 Biologics in Spine Surgery Market Competition by Manufacturers
2.1 Global Biologics in Spine Surgery Sales Market Share by Manufacturers (2017-2022)
2.2 Global Biologics in Spine Surgery Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Biologics in Spine Surgery Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Biologics in Spine Surgery Manufacturing Sites, Area Served, Product Type
2.5 Biologics in Spine Surgery Market Competitive Situation and Trends
2.5.1 Biologics in Spine Surgery Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Biologics in Spine Surgery Players Market Share by Revenue
2.5.3 Global Biologics in Spine Surgery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Biologics in Spine Surgery Retrospective Market Scenario by Region
3.1 Global Biologics in Spine Surgery Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Biologics in Spine Surgery Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Biologics in Spine Surgery Market Facts & Figures by Country
3.3.1 North America Biologics in Spine Surgery Sales by Country
3.3.2 North America Biologics in Spine Surgery Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Biologics in Spine Surgery Market Facts & Figures by Country
3.4.1 Europe Biologics in Spine Surgery Sales by Country
3.4.2 Europe Biologics in Spine Surgery Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Biologics in Spine Surgery Market Facts & Figures by Region
3.5.1 Asia Pacific Biologics in Spine Surgery Sales by Region
3.5.2 Asia Pacific Biologics in Spine Surgery Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Biologics in Spine Surgery Market Facts & Figures by Country
3.6.1 Latin America Biologics in Spine Surgery Sales by Country
3.6.2 Latin America Biologics in Spine Surgery Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Biologics in Spine Surgery Market Facts & Figures by Country
3.7.1 Middle East and Africa Biologics in Spine Surgery Sales by Country
3.7.2 Middle East and Africa Biologics in Spine Surgery Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Biologics in Spine Surgery Historic Market Analysis by Type
4.1 Global Biologics in Spine Surgery Sales Market Share by Type (2017-2022)
4.2 Global Biologics in Spine Surgery Revenue Market Share by Type (2017-2022)
4.3 Global Biologics in Spine Surgery Price by Type (2017-2022)
5 Global Biologics in Spine Surgery Historic Market Analysis by Application
5.1 Global Biologics in Spine Surgery Sales Market Share by Application (2017-2022)
5.2 Global Biologics in Spine Surgery Revenue Market Share by Application (2017-2022)
5.3 Global Biologics in Spine Surgery Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Biologics in Spine Surgery Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Medtronic Biologics in Spine Surgery Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 J &J (DePuy Synthes)
6.2.1 J &J (DePuy Synthes) Corporation Information
6.2.2 J &J (DePuy Synthes) Description and Business Overview
6.2.3 J &J (DePuy Synthes) Biologics in Spine Surgery Sales, Revenue and Gross Margin (2017-2022)
6.2.4 J &J (DePuy Synthes) Biologics in Spine Surgery Product Portfolio
6.2.5 J &J (DePuy Synthes) Recent Developments/Updates
6.3 SeaSpine
6.3.1 SeaSpine Corporation Information
6.3.2 SeaSpine Description and Business Overview
6.3.3 SeaSpine Biologics in Spine Surgery Sales, Revenue and Gross Margin (2017-2022)
6.3.4 SeaSpine Biologics in Spine Surgery Product Portfolio
6.3.5 SeaSpine Recent Developments/Updates
6.4 Xtant Medical
6.4.1 Xtant Medical Corporation Information
6.4.2 Xtant Medical Description and Business Overview
6.4.3 Xtant Medical Biologics in Spine Surgery Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Xtant Medical Biologics in Spine Surgery Product Portfolio
6.4.5 Xtant Medical Recent Developments/Updates
6.5 Zimmer Biomet
6.5.1 Zimmer Biomet Corporation Information
6.5.2 Zimmer Biomet Description and Business Overview
6.5.3 Zimmer Biomet Biologics in Spine Surgery Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Zimmer Biomet Biologics in Spine Surgery Product Portfolio
6.5.5 Zimmer Biomet Recent Developments/Updates
6.6 Stryker
6.6.1 Stryker Corporation Information
6.6.2 Stryker Description and Business Overview
6.6.3 Stryker Biologics in Spine Surgery Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Stryker Biologics in Spine Surgery Product Portfolio
6.6.5 Stryker Recent Developments/Updates
6.7 Straumann
6.6.1 Straumann Corporation Information
6.6.2 Straumann Description and Business Overview
6.6.3 Straumann Biologics in Spine Surgery Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Straumann Biologics in Spine Surgery Product Portfolio
6.7.5 Straumann Recent Developments/Updates
6.8 Wright Medical Group
6.8.1 Wright Medical Group Corporation Information
6.8.2 Wright Medical Group Description and Business Overview
6.8.3 Wright Medical Group Biologics in Spine Surgery Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Wright Medical Group Biologics in Spine Surgery Product Portfolio
6.8.5 Wright Medical Group Recent Developments/Updates
6.9 Hans Biomed
6.9.1 Hans Biomed Corporation Information
6.9.2 Hans Biomed Description and Business Overview
6.9.3 Hans Biomed Biologics in Spine Surgery Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Hans Biomed Biologics in Spine Surgery Product Portfolio
6.9.5 Hans Biomed Recent Developments/Updates
6.10 Arthrex
6.10.1 Arthrex Corporation Information
6.10.2 Arthrex Description and Business Overview
6.10.3 Arthrex Biologics in Spine Surgery Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Arthrex Biologics in Spine Surgery Product Portfolio
6.10.5 Arthrex Recent Developments/Updates
7 Biologics in Spine Surgery Manufacturing Cost Analysis
7.1 Biologics in Spine Surgery Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Biologics in Spine Surgery
7.4 Biologics in Spine Surgery Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Biologics in Spine Surgery Distributors List
8.3 Biologics in Spine Surgery Customers
9 Biologics in Spine Surgery Market Dynamics
9.1 Biologics in Spine Surgery Industry Trends
9.2 Biologics in Spine Surgery Market Drivers
9.3 Biologics in Spine Surgery Market Challenges
9.4 Biologics in Spine Surgery Market Restraints
10 Global Market Forecast
10.1 Biologics in Spine Surgery Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Biologics in Spine Surgery by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Biologics in Spine Surgery by Type (2023-2028)
10.2 Biologics in Spine Surgery Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Biologics in Spine Surgery by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Biologics in Spine Surgery by Application (2023-2028)
10.3 Biologics in Spine Surgery Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Biologics in Spine Surgery by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Biologics in Spine Surgery by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Biologics in Spine Surgery Sales Growth Rate Comparison by Type (2022-2028) & (Units) & (US$ Million)
Table 2. Global Biologics in Spine Surgery Sales Growth Rate Comparison by Application (2022-2028) & (Units) & (US$ Million)
Table 3. Global Biologics in Spine Surgery Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Biologics in Spine Surgery Market Competitive Situation by Manufacturers in 2021
Table 5. Global Biologics in Spine Surgery Sales (Units) of Key Manufacturers (2017-2022)
Table 6. Global Biologics in Spine Surgery Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Biologics in Spine Surgery Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Biologics in Spine Surgery Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Biologics in Spine Surgery Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Biologics in Spine Surgery Manufacturing Sites and Area Served
Table 11. Manufacturers Biologics in Spine Surgery Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Biologics in Spine Surgery by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologics in Spine Surgery as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Biologics in Spine Surgery Sales by Region (2017-2022) & (Units)
Table 16. Global Biologics in Spine Surgery Sales Market Share by Region (2017-2022)
Table 17. Global Biologics in Spine Surgery Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Biologics in Spine Surgery Revenue Market Share by Region (2017-2022)
Table 19. North America Biologics in Spine Surgery Sales by Country (2017-2022) & (Units)
Table 20. North America Biologics in Spine Surgery Sales Market Share by Country (2017-2022)
Table 21. North America Biologics in Spine Surgery Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Biologics in Spine Surgery Revenue Market Share by Country (2017-2022)
Table 23. Europe Biologics in Spine Surgery Sales by Country (2017-2022) & (Units)
Table 24. Europe Biologics in Spine Surgery Sales Market Share by Country (2017-2022)
Table 25. Europe Biologics in Spine Surgery Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Biologics in Spine Surgery Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Biologics in Spine Surgery Sales by Region (2017-2022) & (Units)
Table 28. Asia Pacific Biologics in Spine Surgery Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Biologics in Spine Surgery Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Biologics in Spine Surgery Revenue Market Share by Region (2017-2022)
Table 31. Latin America Biologics in Spine Surgery Sales by Country (2017-2022) & (Units)
Table 32. Latin America Biologics in Spine Surgery Sales Market Share by Country (2017-2022)
Table 33. Latin America Biologics in Spine Surgery Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Biologics in Spine Surgery Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Biologics in Spine Surgery Sales by Country (2017-2022) & (Units)
Table 36. Middle East and Africa Biologics in Spine Surgery Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Biologics in Spine Surgery Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Biologics in Spine Surgery Revenue Market Share by Country (2017-2022)
Table 39. Global Biologics in Spine Surgery Sales by Type (2017-2022) & (Units)
Table 40. Global Biologics in Spine Surgery Sales Market Share by Type (2017-2022)
Table 41. Global Biologics in Spine Surgery Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Biologics in Spine Surgery Revenue Share by Type (2017-2022)
Table 43. Global Biologics in Spine Surgery Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Biologics in Spine Surgery Sales (Units) by Application (2017-2022)
Table 45. Global Biologics in Spine Surgery Sales Market Share by Application (2017-2022)
Table 46. Global Biologics in Spine Surgery Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Biologics in Spine Surgery Revenue Share by Application (2017-2022)
Table 48. Global Biologics in Spine Surgery Price by Application (2017-2022) & (US$/Unit)
Table 49. Medtronic Corporation Information
Table 50. Medtronic Description and Business Overview
Table 51. Medtronic Biologics in Spine Surgery Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Medtronic Biologics in Spine Surgery Product
Table 53. Medtronic Recent Developments/Updates
Table 54. J &J (DePuy Synthes) Corporation Information
Table 55. J &J (DePuy Synthes) Description and Business Overview
Table 56. J &J (DePuy Synthes) Biologics in Spine Surgery Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. J &J (DePuy Synthes) Biologics in Spine Surgery Product
Table 58. J &J (DePuy Synthes) Recent Developments/Updates
Table 59. SeaSpine Corporation Information
Table 60. SeaSpine Description and Business Overview
Table 61. SeaSpine Biologics in Spine Surgery Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. SeaSpine Biologics in Spine Surgery Product
Table 63. SeaSpine Recent Developments/Updates
Table 64. Xtant Medical Corporation Information
Table 65. Xtant Medical Description and Business Overview
Table 66. Xtant Medical Biologics in Spine Surgery Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Xtant Medical Biologics in Spine Surgery Product
Table 68. Xtant Medical Recent Developments/Updates
Table 69. Zimmer Biomet Corporation Information
Table 70. Zimmer Biomet Description and Business Overview
Table 71. Zimmer Biomet Biologics in Spine Surgery Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Zimmer Biomet Biologics in Spine Surgery Product
Table 73. Zimmer Biomet Recent Developments/Updates
Table 74. Stryker Corporation Information
Table 75. Stryker Description and Business Overview
Table 76. Stryker Biologics in Spine Surgery Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Stryker Biologics in Spine Surgery Product
Table 78. Stryker Recent Developments/Updates
Table 79. Straumann Corporation Information
Table 80. Straumann Description and Business Overview
Table 81. Straumann Biologics in Spine Surgery Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Straumann Biologics in Spine Surgery Product
Table 83. Straumann Recent Developments/Updates
Table 84. Wright Medical Group Corporation Information
Table 85. Wright Medical Group Description and Business Overview
Table 86. Wright Medical Group Biologics in Spine Surgery Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Wright Medical Group Biologics in Spine Surgery Product
Table 88. Wright Medical Group Recent Developments/Updates
Table 89. Hans Biomed Corporation Information
Table 90. Hans Biomed Description and Business Overview
Table 91. Hans Biomed Biologics in Spine Surgery Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Hans Biomed Biologics in Spine Surgery Product
Table 93. Hans Biomed Recent Developments/Updates
Table 94. Arthrex Corporation Information
Table 95. Arthrex Description and Business Overview
Table 96. Arthrex Biologics in Spine Surgery Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Arthrex Biologics in Spine Surgery Product
Table 98. Arthrex Recent Developments/Updates
Table 99. Production Base and Market Concentration Rate of Raw Material
Table 100. Key Suppliers of Raw Materials
Table 101. Biologics in Spine Surgery Distributors List
Table 102. Biologics in Spine Surgery Customers List
Table 103. Biologics in Spine Surgery Market Trends
Table 104. Biologics in Spine Surgery Market Drivers
Table 105. Biologics in Spine Surgery Market Challenges
Table 106. Biologics in Spine Surgery Market Restraints
Table 107. Global Biologics in Spine Surgery Sales Forecast by Type (2023-2028) & (Units)
Table 108. Global Biologics in Spine Surgery Sales Market Share Forecast by Type (2023-2028)
Table 109. Global Biologics in Spine Surgery Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 110. Global Biologics in Spine Surgery Revenue Market Share Forecast by Type (2023-2028)
Table 111. Global Biologics in Spine Surgery Sales Forecast by Application (2023-2028) & (Units)
Table 112. Global Biologics in Spine Surgery Sales Market Share Forecast by Application (2023-2028)
Table 113. Global Biologics in Spine Surgery Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 114. Global Biologics in Spine Surgery Revenue Market Share Forecast by Application (2023-2028)
Table 115. Global Biologics in Spine Surgery Sales Forecast by Region (2023-2028) & (Units)
Table 116. Global Biologics in Spine Surgery Sales Market Share Forecast by Region (2023-2028)
Table 117. Global Biologics in Spine Surgery Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 118. Global Biologics in Spine Surgery Revenue Market Share Forecast by Region (2023-2028)
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Biologics in Spine Surgery
Figure 2. Global Biologics in Spine Surgery Market Share by Type in 2021 & 2028
Figure 3. Bone Graft Product Picture
Figure 4. Bone Graft Substitute Product Picture
Figure 5. Platelet Rich Plasma (PRP) Product Picture
Figure 6. Other Product Picture
Figure 7. Global Biologics in Spine Surgery Market Share by Application in 2021 & 2028
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Biologics in Spine Surgery Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Biologics in Spine Surgery Market Size (2017-2028) & (US$ Million)
Figure 13. Global Biologics in Spine Surgery Sales (2017-2028) & (Units)
Figure 14. Biologics in Spine Surgery Sales Share by Manufacturers in 2021
Figure 15. Global Biologics in Spine Surgery Revenue Share by Manufacturers in 2021
Figure 16. The Global 5 and 10 Largest Biologics in Spine Surgery Players: Market Share by Revenue in 2021
Figure 17. Biologics in Spine Surgery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Biologics in Spine Surgery Sales Market Share by Region (2017-2022)
Figure 19. Global Biologics in Spine Surgery Sales Market Share by Region in 2021
Figure 20. Global Biologics in Spine Surgery Revenue Market Share by Region (2017-2022)
Figure 21. Global Biologics in Spine Surgery Revenue Market Share by Region in 2021
Figure 22. United States Biologics in Spine Surgery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Canada Biologics in Spine Surgery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Germany Biologics in Spine Surgery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. France Biologics in Spine Surgery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. U.K. Biologics in Spine Surgery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Italy Biologics in Spine Surgery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Russia Biologics in Spine Surgery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. China Biologics in Spine Surgery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Japan Biologics in Spine Surgery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. South Korea Biologics in Spine Surgery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. India Biologics in Spine Surgery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Australia Biologics in Spine Surgery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. China Taiwan Biologics in Spine Surgery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Indonesia Biologics in Spine Surgery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Thailand Biologics in Spine Surgery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Malaysia Biologics in Spine Surgery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Mexico Biologics in Spine Surgery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Brazil Biologics in Spine Surgery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Argentina Biologics in Spine Surgery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Turkey Biologics in Spine Surgery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Saudi Arabia Biologics in Spine Surgery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. UAE Biologics in Spine Surgery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Sales Market Share of Biologics in Spine Surgery by Type (2017-2022)
Figure 45. Manufacturing Cost Structure of Biologics in Spine Surgery
Figure 46. Manufacturing Process Analysis of Biologics in Spine Surgery
Figure 47. Biologics in Spine Surgery Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’